04
Sep
Montpellier, France, September 4th 2025 : Cilcare, a biotechnology company specializing in auditory sciences, is pleased to announce the appointment of Camille Rochmann, PharmD, as Evidence, Value & Access Senior Manager. In this role, Camille will lead Cilcare’s strategy for evidence generation and market access, ensuring that innovation in hearing health is supported by robust data and aligned with regulatory and payer expectations from the earliest stages of development.
Camille brings over seven years of experience at Sanofi, where she worked...